Wockhardt's Zaynich, an investigational antibiotic, has been under evaluation for its efficacy in treating complicated ...

Wockhardt now intends to file a new drug application (NDA) with the USFDA and seek marketing authorisation application with ...

Pursuant to Regulation 30 of SEBI Listing Regulations please find attached Press Release titled Zaynich(Zidebactum/Cefepime. WCK 5222)achieves over 97% Efficacy in Clinical Study for serious ...

Sensex Today | Stock Market LIVE Updates: The domestic benchmark indices Sensex and Nifty ended higher ahead of Union Budget on Saturday. Sensex rose 741 points or 0.97% to 77,500.57 while Nifty 50 ...

Expert Rev Anti Infect Ther. 2011;9(1):81-96. In summary, for empiric treatment of infections of the CNS following surgery and prophylactic antibiotics for trauma (Table 2) based on consensus ...

3 cases), antibiotics in 13 cases (cefepime, imipenem, rifampicin, ciprofloxacin, moxifloxacin, ofloxacin), other antifungal agents in 6 cases (liposomal amphotericin B, caspofungin ...

Its lead combination - cefepime-taniborbactam – is being developed in phase 3 trials for complicated urinary tract infections (cUTI), hospital-acquired bacterial pneumonia, and ventilator ...